Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 67.30% is 335% above its 5-year average of 15.47%, near the high end of its 5-year range (-99.01%–67.30%).
21.19% above its 12-month average of 55.53%.
Reported quarterly gross margin; no daily interpolation. Q3 FY2026 (2026-06-30): 59.94%.
GROSS MARGIN
67.30%
GROSS MARGIN AVG TTM
55.53%
GROSS MARGIN AVG 3Y
46.03%
GROSS MARGIN AVG 5Y
15.47%
GROSS MARGIN AVG 10Y
13.29%
GROSS MARGIN AVG 15Y
35.94%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+21.19%
CURRENT VS 3Y AVG
+46.20%
CURRENT VS 5Y AVG
+335.10%
CURRENT VS 10Y AVG
+406.55%
CURRENT VS 15Y AVG
+87.26%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.38%
median of 740 covered companies
CURRENT VS SECTOR MEDIAN
+66.67%
vs the sector median at left
NeuroOne Medical Technologies Corporation
Market Cap
$9.89M
Gross Margin
67.30%
TTM Avg
55.53%
3Y Avg
46.03%
5Y Avg
15.47%
Market Cap
$9.72M
Gross Margin
-3767.20%
TTM Avg
-1960.46%
3Y Avg
-1022.20%
5Y Avg
-664.64%
Market Cap
$9.37M
Gross Margin
92.64%
TTM Avg
97.85%
3Y Avg
48.93%
5Y Avg
32.62%
Market Cap
$9.33M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.05M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$9.18M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.44M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeuroOne Medical Technologies Corporation (NMTC) | $9.89M | 67.30% | 55.53% | 46.03% | 15.47% |
| Ainos, Inc. (AIMD)vs › | $9.72M | -3767.20% | -1960.46% | -1022.20% | -664.64% |
| Lifeward Ltd. (LFWD)vs › | $9.92M | 35.95% | 35.13% | 34.24% | 39.24% |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.37M | 92.64% | 97.85% | 48.93% | 32.62% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.33M | 0.00% | 0.00% | 0.00% | 0.00% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.05M | 0.00% | 0.00% | 0.00% | 0.00% |
| MetaVia Inc. (MTVA)vs › | $10.08M | 0.00% | 0.00% | 0.00% | 0.00% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.18M | 0.00% | 0.00% | 0.00% | 0.00% |
| Satellos Bioscience Inc. (MSLE)vs › | $10.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| Polyrizon Ltd. (PLRZ)vs › | $10.47M | N/A | 0.00% | 0.00% | 0.00% |
Gross Margin
67.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 59.94% |
| 2026-03-31 | 53.81% |
| 2025-12-31 | 54.20% |
| 2025-09-30 | 55.77% |
| 2025-06-30 | 53.94% |
| 2025-03-31 | 55.61% |
| 2024-12-31 | 58.85% |
| 2024-09-30 | 51.81% |
| 2024-06-30 | 34.13% |
| 2024-03-31 | 28.35% |
| 2023-12-31 | 27.24% |
| 2023-09-30 | 26.11% |
| 2023-06-30 | 38.68% |
| 2023-03-31 | 6.76% |
| 2022-12-31 | -10.74% |
| 2022-09-30 | -21.90% |
| 2022-06-30 | -20.01% |
| 2022-03-31 | -99.01% |
| 2021-12-31 | -38.81% |
| 2021-09-30 | -35.44% |
| 2021-06-30 | -54.47% |
| 2021-03-31 | -115.81% |
| 2020-12-31 | -52.69% |
| 2020-09-30 | 100.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 100.00% |
| 2015-12-31 | 100.00% |
| 2015-09-30 | 100.00% |
| 2015-06-30 | 100.00% |
| 2015-03-31 | 100.00% |
| 2014-12-31 | 100.00% |
| 2014-09-30 | 100.00% |
| 2014-06-30 | 100.00% |
| 2014-03-31 | 100.00% |
| 2013-12-31 | 100.00% |
| 2013-09-30 | 100.00% |
| 2013-06-30 | 100.00% |
| 2013-03-31 | 100.00% |
| 2012-12-31 | 100.00% |
| 2012-09-30 | 100.00% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | -619.87% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
